Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nenghui Wang
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis
Scientific Reports
Multidisciplinary
Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases
Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Absence of Appl2 Sensitizes Endotoxin Shock Through Activation of PI3K/Akt Pathway
Cell and Bioscience
Biochemistry
Genetics
Molecular Biology
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
PI3K-PKB/Akt Pathway
Cold Spring Harbor perspectives in biology
Biochemistry
Genetics
Molecular Biology
Applying 89Zr-Transferrin to Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins
